We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ViaCyte Aims to Cure Diabetes with Pancreatic Cell-Delivery Systems
ViaCyte Aims to Cure Diabetes with Pancreatic Cell-Delivery Systems
ViaCyte’s implantable pouch filled with stem-cell-derived pancreatic cells is advancing in a first-in-human type 1 diabetes trial, showing clinically meaningful improvements in glycemic control and blood sugar, accompanied by a 70 percent decrease from the peak insulin dose.